Lumisight safety study for breast cancer lumpectomy
Part of Cancer, Immune system & allergy, Skin clinical trials.
This study is checking how safe Lumisight is in people having breast cancer surgery called a lumpectomy. Lumisight is a dye that helps surgeons see remaining cancer during the operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with primary breast cancer.
- You are scheduled to have a lumpectomy (surgery to remove the tumor).
- You are willing to follow the study procedures.
- You have not had an allergic reaction to pegulicianine (Lumisight) before.
- Your doctor agrees that it is okay for you to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device called LumiSystem that helps doctors check if all cancer cells are removed during breast cancer surgery. The goal is to see if using it improves surgery outcomes.
This study looks at a more personalized way to follow up after breast-conserving surgery (lumpectomy). It may use extra imaging scans to detect any return of cancer early, which could help you feel more secure and get treatment sooner if needed.
This study tests a new imaging tool that helps surgeons see cancer margins in real time during a lumpectomy, aiming to reduce the need for a second surgery. It is for women with early-stage breast cancer who are planning a lumpectomy.
This trial tests a dye that makes lung cancer cells glow during surgery, helping surgeons remove more of the tumor. It's for people who are already scheduled for lung cancer surgery.
This trial tests a dye called Cytalux that helps surgeons see cancer during surgery. You get the dye before surgery, and it makes cancer cells glow under a special light. This could help doctors remove more cancer.
This study compares two ways to mark and remove cancerous lymph nodes under the arm during breast cancer surgery. The new method uses a special marker (LuminoMark) to help the surgeon find the right lymph nodes, which may improve accuracy and reduce side effects.
Hear when a new Hypersensitivity Reactions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.